Home > National Drug Code (NDC) > Actoplus Met

Actoplus Met - 64764-155-18 - (pioglitazone and metformin hydrochloride)

Alphabetical Index


Drug Information of Actoplus Met

Product NDC: 64764-155
Proprietary Name: Actoplus Met
Non Proprietary Name: pioglitazone and metformin hydrochloride
Active Ingredient(s): 500; 15    mg/1; mg/1 & nbsp;   pioglitazone and metformin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Actoplus Met

Product NDC: 64764-155
Labeler Name: Takeda Pharmaceuticals America, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021842
Marketing Category: NDA
Start Marketing Date: 20050829

Package Information of Actoplus Met

Package NDC: 64764-155-18
Package Description: 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-155-18)

NDC Information of Actoplus Met

NDC Code 64764-155-18
Proprietary Name Actoplus Met
Package Description 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-155-18)
Product NDC 64764-155
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pioglitazone and metformin hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20050829
Marketing Category Name NDA
Labeler Name Takeda Pharmaceuticals America, Inc.
Substance Name METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Strength Number 500; 15
Strength Unit mg/1; mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of Actoplus Met


General Information